Cargando…

A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion

SIMPLE SUMMARY: Lymphovascular invasion (LVI), the presence of tumor cells in lymphovascular spaces, is associated with an increased risk of metastasis and is considered an independent prognostic indicator. LVI is a clinicopathological hallmark of inflammatory breast cancer (IBC), an understudied bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rickard, Ashlyn G., Sannareddy, Dorababu S., Bennion, Alexandra, Patel, Pranalee, Sauer, Scott J., Rouse, Douglas C., Bouchal, Samantha, Liu, Harrison, Dewhirst, Mark W., Palmer, Gregory M., Devi, Gayathri R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137020/
https://www.ncbi.nlm.nih.gov/pubmed/37190189
http://dx.doi.org/10.3390/cancers15082261
_version_ 1785032358839189504
author Rickard, Ashlyn G.
Sannareddy, Dorababu S.
Bennion, Alexandra
Patel, Pranalee
Sauer, Scott J.
Rouse, Douglas C.
Bouchal, Samantha
Liu, Harrison
Dewhirst, Mark W.
Palmer, Gregory M.
Devi, Gayathri R.
author_facet Rickard, Ashlyn G.
Sannareddy, Dorababu S.
Bennion, Alexandra
Patel, Pranalee
Sauer, Scott J.
Rouse, Douglas C.
Bouchal, Samantha
Liu, Harrison
Dewhirst, Mark W.
Palmer, Gregory M.
Devi, Gayathri R.
author_sort Rickard, Ashlyn G.
collection PubMed
description SIMPLE SUMMARY: Lymphovascular invasion (LVI), the presence of tumor cells in lymphovascular spaces, is associated with an increased risk of metastasis and is considered an independent prognostic indicator. LVI is a clinicopathological hallmark of inflammatory breast cancer (IBC), an understudied but highly lethal variant presenting as diffuse tumor cell clusters (tumor emboli) invading throughout the breast and dermal lymphatics, causing breast erythema and edema and often without a distinct tumor mass. There is a lack of preclinical IBC models that monitor spatial and temporal changes during growth and migration of individual tumor clusters. Herein, we generated a transgenic murine model with red fluorescent lymphatics that, with implantation of tumor cells in a dorsal skin window chamber, simulate IBC characteristics. This model enables intravital imaging and quantitative analysis of collectively migrating tumor cells and vessel density in the local tumor microenvironment, an innovation that can be widely applied to various cancers exhibiting LVI. ABSTRACT: Inflammatory breast cancer (IBC), an understudied and lethal breast cancer, is often misdiagnosed due to its unique presentation of diffuse tumor cell clusters in the skin and dermal lymphatics. Here, we describe a window chamber technique in combination with a novel transgenic mouse model that has red fluorescent lymphatics (ProxTom RFP Nu/Nu) to simulate IBC clinicopathological hallmarks. Various breast cancer cells stably transfected to express green or red fluorescent reporters were transplanted into mice bearing dorsal skinfold window chambers. Intravital fluorescence microscopy and the in vivo imaging system (IVIS) were used to serially quantify local tumor growth, motility, length density of lymph and blood vessels, and degree of tumor cell lymphatic invasion over 0–140 h. This short-term, longitudinal imaging time frame in studying transient or dynamic events of diffuse and collectively migrating tumor cells in the local environment and quantitative analysis of the tumor area, motility, and vessel characteristics can be expanded to investigate other cancer cell types exhibiting lymphovascular invasion, a key step in metastatic dissemination. It was found that these models were able to effectively track tumor cluster migration and dissemination, which is a hallmark of IBC clinically, and was recapitulated in these mouse models.
format Online
Article
Text
id pubmed-10137020
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101370202023-04-28 A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion Rickard, Ashlyn G. Sannareddy, Dorababu S. Bennion, Alexandra Patel, Pranalee Sauer, Scott J. Rouse, Douglas C. Bouchal, Samantha Liu, Harrison Dewhirst, Mark W. Palmer, Gregory M. Devi, Gayathri R. Cancers (Basel) Article SIMPLE SUMMARY: Lymphovascular invasion (LVI), the presence of tumor cells in lymphovascular spaces, is associated with an increased risk of metastasis and is considered an independent prognostic indicator. LVI is a clinicopathological hallmark of inflammatory breast cancer (IBC), an understudied but highly lethal variant presenting as diffuse tumor cell clusters (tumor emboli) invading throughout the breast and dermal lymphatics, causing breast erythema and edema and often without a distinct tumor mass. There is a lack of preclinical IBC models that monitor spatial and temporal changes during growth and migration of individual tumor clusters. Herein, we generated a transgenic murine model with red fluorescent lymphatics that, with implantation of tumor cells in a dorsal skin window chamber, simulate IBC characteristics. This model enables intravital imaging and quantitative analysis of collectively migrating tumor cells and vessel density in the local tumor microenvironment, an innovation that can be widely applied to various cancers exhibiting LVI. ABSTRACT: Inflammatory breast cancer (IBC), an understudied and lethal breast cancer, is often misdiagnosed due to its unique presentation of diffuse tumor cell clusters in the skin and dermal lymphatics. Here, we describe a window chamber technique in combination with a novel transgenic mouse model that has red fluorescent lymphatics (ProxTom RFP Nu/Nu) to simulate IBC clinicopathological hallmarks. Various breast cancer cells stably transfected to express green or red fluorescent reporters were transplanted into mice bearing dorsal skinfold window chambers. Intravital fluorescence microscopy and the in vivo imaging system (IVIS) were used to serially quantify local tumor growth, motility, length density of lymph and blood vessels, and degree of tumor cell lymphatic invasion over 0–140 h. This short-term, longitudinal imaging time frame in studying transient or dynamic events of diffuse and collectively migrating tumor cells in the local environment and quantitative analysis of the tumor area, motility, and vessel characteristics can be expanded to investigate other cancer cell types exhibiting lymphovascular invasion, a key step in metastatic dissemination. It was found that these models were able to effectively track tumor cluster migration and dissemination, which is a hallmark of IBC clinically, and was recapitulated in these mouse models. MDPI 2023-04-12 /pmc/articles/PMC10137020/ /pubmed/37190189 http://dx.doi.org/10.3390/cancers15082261 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rickard, Ashlyn G.
Sannareddy, Dorababu S.
Bennion, Alexandra
Patel, Pranalee
Sauer, Scott J.
Rouse, Douglas C.
Bouchal, Samantha
Liu, Harrison
Dewhirst, Mark W.
Palmer, Gregory M.
Devi, Gayathri R.
A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title_full A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title_fullStr A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title_full_unstemmed A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title_short A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular Invasion
title_sort novel preclinical murine model to monitor inflammatory breast cancer tumor growth and lymphovascular invasion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137020/
https://www.ncbi.nlm.nih.gov/pubmed/37190189
http://dx.doi.org/10.3390/cancers15082261
work_keys_str_mv AT rickardashlyng anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT sannareddydorababus anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT bennionalexandra anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT patelpranalee anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT sauerscottj anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT rousedouglasc anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT bouchalsamantha anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT liuharrison anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT dewhirstmarkw anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT palmergregorym anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT devigayathrir anovelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT rickardashlyng novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT sannareddydorababus novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT bennionalexandra novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT patelpranalee novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT sauerscottj novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT rousedouglasc novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT bouchalsamantha novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT liuharrison novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT dewhirstmarkw novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT palmergregorym novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion
AT devigayathrir novelpreclinicalmurinemodeltomonitorinflammatorybreastcancertumorgrowthandlymphovascularinvasion